Michel Hanen-Smith
Optometrist · Minneapolis, MNNPI 1326119223
Payments from drug & device makers
Across 64 payments — averaging $19.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$229
- Novartis$148
- Coopervision Inc.$133
- Oyster Point Pharma, Inc.$131
- Johnson & Johnson Vision Care, Inc.$130
- Sun Pharmaceutical Industries Inc.$102
- plus $363 from 8 others
What the payments were for
- Food & beverage$1,236100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 11 | $229 |
| Novartis | 9 | $148 |
| Coopervision Inc. | 7 | $133 |
| Oyster Point Pharma, Inc. | 8 | $131 |
| Johnson & Johnson Vision Care, Inc. | 6 | $130 |
| Sun Pharmaceutical Industries Inc. | 6 | $102 |
| Maculogix, Inc. | 5 | $92 |
| Menicon America Inc | 1 | $68 |
| Alcon Research LLC | 3 | $54 |
| Dompe US, Inc. | 3 | $48 |
| Tarsus Pharmaceuticals, Inc. | 2 | $34 |
| Mallinckrodt Hospital Products Inc. | 1 | $24 |
| Harrow Eye, LLC | 1 | $23 |
| ABB Con-cise Optical Group LLC | 1 | $19 |
How this compares
$1,236 in reported general payments places this provider in the 80th percentile of 826 optometrist providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 119 | $91,969 |
| LumiganBimatoprost | 63 | $30,396 |
| Cyclosporine | 50 | $22,676 |
| XiidraLifitegrast | 24 | $19,198 |
| ZioptanTafluprost/Pf | 19 | $8,507 |
| RhopressaNetarsudil Mesylate | 17 | $6,492 |
| Fluorometholone | 43 | $3,472 |
| Loteprednol Etabonate | 14 | $2,683 |
| Brimonidine Tartrate | 23 | $2,609 |
| Travoprost | 12 | $2,522 |
| Prednisolone Acetate | 48 | $2,325 |
| Timolol Maleate | 34 | $1,862 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 27 | $1,511 |
| Diclofenac Sodium | 51 | $1,155 |
| Latanoprost | 41 | $917 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Minneapolis
- Joshua HanenMinneapolis$40K
- Sarah BaerMinneapolis$5K
- Marcie NicholsMinneapolis$4K
- Emmalee ToldoMinneapolis$3K
- Gina WesleyMedina$2.6M
- Britt GustafsonEden Prairie$684K
- Zachary HollandEdina$372K
- Jacob LangStillwater$264K
- Nicholas ColatrellaSartell$84K
- Jessica HeckmanRogers$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.